Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C, Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K.

Clin Infect Dis. 2019 Aug 12. pii: ciz745. doi: 10.1093/cid/ciz745. [Epub ahead of print]

PMID:
31630166
2.

A Mobile Application for Exercise Intervention in People Living with HIV.

Bonato M, Turrini F, DE Zan V, Meloni A, Plebani M, Brambilla E, Giordani A, Vitobello C, Caccia R, Piacentini MF, LA Torre A, Lazzarin A, Merati G, Galli L, Cinque P.

Med Sci Sports Exerc. 2019 Aug 14. doi: 10.1249/MSS.0000000000002125. [Epub ahead of print]

PMID:
31415448
3.

Rechallenging to Hydroxycarbamide Post Thalidomide Treatment and Response in a Non Transfusion-Dependent Patient, is it Possible?

Ricchi P, Costantini S, Spasiano A, Cinque P, Di Matola T, Ammirabile M, Filosa A.

Indian J Hematol Blood Transfus. 2019 Jul;35(3):587-589. doi: 10.1007/s12288-019-01093-x. Epub 2019 Feb 11. No abstract available.

PMID:
31388283
4.

Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study).

Castagna A, Muccini C, Galli L, Bigoloni A, Poli A, Spagnuolo V, Nozza S, Racca S, Galli A, Cinque P, Carini E, Lazzarin A.

J Antimicrob Chemother. 2019 Jul 1;74(7):2039-2046. doi: 10.1093/jac/dkz138.

PMID:
31225610
5.

Longitudinal trend analysis of serum transferrin receptor-1 level in a cohort of patients affected by non-transfusion dependent thalassaemia.

Ricchi P, Ammirabile M, Costantini S, Spasiano A, Cinque P, Gargiulo B, Filosa A.

Br J Haematol. 2019 Sep;186(5):e121-e123. doi: 10.1111/bjh.15948. Epub 2019 May 7. No abstract available.

PMID:
31066028
6.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G.

Ann Neurol. 2019 Apr;85(4):606-610. doi: 10.1002/ana.25437. Epub 2019 Mar 5.

PMID:
30761586
7.

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?

Trunfio M, Pinnetti C, Focà E, Bai F, Maffongelli G, Celani L, Cinque P, Celotti A, Andreoni M, D'Arminio Monforte A, D'Ettorre G, Antinori A, Calcagno A.

AIDS. 2019 Mar 15;33(4):759-762. doi: 10.1097/QAD.0000000000002091.

PMID:
30531317
8.

Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major.

Casale M, Marsella M, Ammirabile M, Spasiano A, Costantini S, Cinque P, Ricchi P, Filosa A.

Blood Transfus. 2019 May;17(3):165-170. doi: 10.2450/2018.0092-18. Epub 2018 Jun 26.

9.

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment.

Borderi M, Angarano G, Antinori A, Chirianni A, Cinque P, D'Arminio Monforte A, Di Biagio A, Di Perri G, Galli M, Gori A, Lazzarin A, Mussini C, Perno CF, Quirino T, Rizzardini G, Calza L, Viale P, Acone B, Andreoni M.

New Microbiol. 2018 Apr;41(2):112-117.

10.

The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.

Ricchi P, Meloni A, Spasiano A, Costantini S, Pepe A, Cinque P, Filosa A.

Br J Haematol. 2018 Mar;180(5):721-726. doi: 10.1111/bjh.15083. Epub 2018 Jan 24.

PMID:
29363758
11.

Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.

Ferretti F, Bestetti A, Yiannoutsos CT, Musick BS, Gerevini S, Passeri L, Bossolasco S, Boschini A, Franciotta D, Lazzarin A, Cinque P.

Clin Infect Dis. 2018 Jun 18;67(1):65-72. doi: 10.1093/cid/ciy030.

PMID:
29346632
12.

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.

Nozza S, Cozzi-Lepri A, Bai F, Rusconi S, Gori A, Cinque P, Ammassari A, Caramello P, Tambussi G, D'Arminio Monforte A, Marchetti G; Icona Foundation Study Group.

PLoS One. 2017 Dec 5;12(12):e0189045. doi: 10.1371/journal.pone.0189045. eCollection 2017.

13.

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Rossi F, Prosperini L, De Rossi N, Capra R, Rivanera D, Li X, Cinque P, Passeri L, Pozzilli C, Viscidi R.

Viral Immunol. 2017 Oct;30(8):622-626. doi: 10.1089/vim.2017.0039. Epub 2017 Aug 24.

PMID:
28836899
14.

Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.

Ricchi P, Meloni A, Costantini S, Spasiano A, Di Matola T, Pepe A, Cinque P, Filosa A.

Ann Hematol. 2017 Sep;96(9):1541-1546. doi: 10.1007/s00277-017-3057-z. Epub 2017 Jul 14.

PMID:
28707012
15.

Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Cinque P, Saporito C, Filosa A, Pagano L.

Hematology. 2017 Aug;22(7):437-443. doi: 10.1080/10245332.2017.1289304. Epub 2017 Feb 20.

PMID:
28218017
16.

A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers.

Bonato M, Galli L, Passeri L, Longo V, Pavei G, Bossolasco S, Bertocchi C, Cernuschi M, Balconi G, Merati G, Lazzarin A, La Torre A, Cinque P.

BMC Infect Dis. 2017 Jan 11;17(1):61. doi: 10.1186/s12879-016-2095-9.

17.

Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.

Ricchi P, Costantini S, Spasiano A, Di Matola T, Cinque P, Filosa A.

Am J Hematol. 2017 Mar;92(3):E25-E26. doi: 10.1002/ajh.24622. Epub 2017 Feb 1. No abstract available.

18.

Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA.

Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth Joseph S, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S.

J Virus Erad. 2016 Oct 5;2(4):243-250.

19.

No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).

Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A, Cinque P, Nilsson S, Gisslén M.

Virulence. 2017 Jul 4;8(5):599-604. doi: 10.1080/21505594.2016.1212155. Epub 2016 Jul 19.

20.

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.

Ferretti F, Bigoloni A, Passeri L, Galli L, Longo V, Gerevini S, Spagnuolo V, Gisslen M, Zetterberg H, Fuchs D, Cattaneo D, Caramatti G, Lazzarin A, Cinque P, Castagna A.

Medicine (Baltimore). 2016 Jul;95(28):e4144. doi: 10.1097/MD.0000000000004144.

21.

Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.

Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Verna R, Pepe A, Cinque P, Saporito C, Filosa A, Pagano L.

Blood Transfus. 2016 Nov;14(6):538-540. doi: 10.2450/2016.0279-15. Epub 2016 May 3. No abstract available.

22.

The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with Non-Transfusion-Dependent Thalassemia.

Ricchi P, Costantini S, Spasiano A, De Dominicis G, Di Matola T, Cinque P, Ammirabile M, Marsella M, Filosa A.

Blood Cells Mol Dis. 2016 Mar;57:97-9. doi: 10.1016/j.bcmd.2016.01.003. Epub 2016 Jan 16.

PMID:
26810455
23.

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.

Andreoni M, Marcotullio S, Puro V, De Carli G, Tambussi G, Nozza S, Gori A, Rusconi S, Santoro MM, Clementi M, Perno CF, d'Arminio Monforte A, Maggiolo F, Castagna A, De Luca A, Galli M, Giacomelli A, Borderi M, Guaraldi G, Calcagno A, Di Perri G, Bonora S, Mussini C, Di Biagio A, Puoti M, Bruno R, Zuccaro V, Antinori A, Cinque P, Croce D, Restelli U, Rizzardini G, Lazzarin A.

New Microbiol. 2015 Oct;38(4):443-90. Review.

24.

2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment.

Patera AC, Butler SL, Cinque P, Clifford DB, Elston R, Garcea RL, Major EO, Pavlovic D, Peterson IS, Ryan AM, Tyler KL, Weber T; PML Consortium.

J Neurovirol. 2015 Dec;21(6):702-5. doi: 10.1007/s13365-015-0392-5. No abstract available.

PMID:
26501778
25.

JC polyomavirus mutants escape antibody-mediated neutralization.

Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV.

Sci Transl Med. 2015 Sep 23;7(306):306ra151. doi: 10.1126/scitranslmed.aab1720. Epub 2015 Sep 23.

26.

Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.

Alfano M, Cinque P, Giusti G, Proietti S, Nebuloni M, Danese S, D'Alessio S, Genua M, Portale F, Lo Porto M, Singhal PC, Rastaldi MP, Saleem MA, Mavilio D, Mikulak J.

Sci Rep. 2015 Sep 18;5:13647. doi: 10.1038/srep13647.

27.

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy.

Gianotti N, Poli A, Nozza S, Spagnuolo V, Tambussi G, Bossolasco S, Cinque P, Maillard M, Cernuschi M, Galli L, Lazzarin A, Castagna A.

J Int AIDS Soc. 2015 Jul 30;18:20037. doi: 10.7448/IAS.18.1.20037. eCollection 2015.

28.

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Ferretti F, Gisslen M, Cinque P, Price RW.

Curr HIV/AIDS Rep. 2015 Jun;12(2):280-8. doi: 10.1007/s11904-015-0267-7. Review.

PMID:
25860317
29.

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.

Sospedra M, Schippling S, Yousef S, Jelcic I, Bofill-Mas S, Planas R, Stellmann JP, Demina V, Cinque P, Garcea R, Croughs T, Girones R, Martin R.

Clin Infect Dis. 2014 Dec 1;59(11):1588-92. doi: 10.1093/cid/ciu682. Epub 2014 Sep 11.

30.

Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.

Casale M, Citarella S, Filosa A, De Michele E, Palmieri F, Ragozzino A, Amendola G, Pugliese U, Tartaglione I, Della Rocca F, Cinque P, Nobili B, Perrotta S.

Am J Hematol. 2014 Dec;89(12):1102-6. doi: 10.1002/ajh.23844. Epub 2014 Sep 26.

31.

Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategies.

Ferretti F, Gianotti N, Lazzarin A, Cinque P.

Semin Neurol. 2014 Feb;34(1):78-88. doi: 10.1055/s-0034-1372345. Epub 2014 Apr 8. Review.

PMID:
24715491
32.

Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Cartenì G, Filosa A, Cinque P.

Br J Haematol. 2014 Jun;165(6):887-8. doi: 10.1111/bjh.12809. Epub 2014 Feb 26. No abstract available.

PMID:
24571286
33.

Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Vitale M, Di Matola T, Cinque P, Filosa A, Serino D.

Br J Haematol. 2014 Mar;164(5):743-5. doi: 10.1111/bjh.12668. Epub 2013 Nov 20. No abstract available.

PMID:
24251449
34.

Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Pepe A, Cinque P, Pagano L, Casale M, Filosa A, Prossomariti L.

Blood Transfus. 2014 Jan;12 Suppl 1:s124-30. doi: 10.2450/2013.0287-12. Epub 2013 Oct 3.

35.

Susac's syndrome as HIV-associated immune reconstitution inflammatory syndrome.

Ferretti F, Gerevini S, Colombo B, Testa M, Guffanti M, Franciotta D, Bernardi G, Lazzarin A, Cinque P.

AIDS Res Ther. 2013 Sep 3;10(1):22. doi: 10.1186/1742-6405-10-22.

36.

Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.

Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Cinque P, Casale M, Filosa A, Prossomariti L.

Ann Hematol. 2014 Mar;93(3):525-7. doi: 10.1007/s00277-013-1833-y. Epub 2013 Jun 27. No abstract available.

PMID:
23807253
37.

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes.

Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P.

J Neurovirol. 2013 Aug;19(4):351-8. doi: 10.1007/s13365-013-0173-y. Epub 2013 Jun 4.

38.

Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.

Casale M, Cinque P, Ricchi P, Costantini S, Spasiano A, Prossomariti L, Minelli S, Frega V, Filosa A.

Eur J Haematol. 2013 Jul;91(1):69-73. doi: 10.1111/ejh.12121. Epub 2013 May 24.

PMID:
23581970
39.

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.

Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L, Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C.

Blood. 2013 Jun 6;121(23):4740-8. doi: 10.1182/blood-2013-01-476333. Epub 2013 Apr 9.

40.

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.

Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S.

J Infect Dis. 2013 Jun 1;207(11):1703-12. doi: 10.1093/infdis/jit088. Epub 2013 Mar 4.

41.

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M.

J Neurol. 2013 Feb;260(2):620-6. doi: 10.1007/s00415-012-6688-y. Epub 2012 Oct 9.

PMID:
23052602
42.

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders.

Giancola ML, Lorenzini P, Cingolani A, Baldini F, Bossolasco S, Bini T, Monno L, Picchi G, d'Arminio Monforte A, Cinque P, Tozzi V, Antinori A.

AIDS Res Treat. 2012;2012:708456. doi: 10.1155/2012/708456. Epub 2012 Aug 26.

43.

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.

Scientific Coordination Committee, Marcotullio S, Andreoni M, Antinori A, d'Arminio Monforte A, Di Perri G, Galli M, Ippolito G, Perno CF, Rizzardini G, Lazzarin A; Rapporteur Committee, Cinque P, Fares G, Foglia E, Gervasoni C, Murri R, Nozza S, Rusconi S.

New Microbiol. 2012 Jul;35(3):259-77. Epub 2012 Jun 30. No abstract available.

44.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Armignacco O, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Floridia M, Galli M, Mastroianni C, Matteelli A, Mazzotta F, Moroni M, Pal G, Puoti M, Puro V, Rizzardini G, Sagnelli E, Vella S, Vullo V, Lazzarin A; Italian HIV Guidelines Working Group.

New Microbiol. 2012 Apr;35(2):113-59. Epub 2012 Mar 31. No abstract available.

45.

Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study.

Ricchi P, Ammirabile M, Costantini S, Di Matola T, Spasiano A, Genna ML, Cinque P, Prossomariti L.

Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):133-5. doi: 10.1016/j.bcmd.2012.05.012. Epub 2012 Jun 15.

PMID:
22705193
46.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S.

AIDS. 2012 Sep 10;26(14):1765-74. doi: 10.1097/QAD.0b013e328355e6b2.

47.

Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.

Ferrò MT, Franciotta D, Prelle A, Bestetti A, Cinque P.

J Neurovirol. 2012 Oct;18(5):437-40. doi: 10.1007/s13365-012-0110-5. Epub 2012 May 19. No abstract available.

PMID:
22611013
48.

Long-term remission of HIV-associated primary CNS lymphoma achieved with highly active antiretroviral therapy alone.

Travi G, Ferreri AJ, Cinque P, Gerevini S, Ponzoni M, Terreni MR, Lazzarin A, Crippa F.

J Clin Oncol. 2012 Apr 1;30(10):e119-21. doi: 10.1200/JCO.2011.39.9642. Epub 2012 Feb 21. No abstract available.

PMID:
22355047
49.

Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy.

Ferretti F, Boschini A, Iabichino C, Gerevini S, De Nardi P, Guffanti M, Balconi G, Lazzarin A, Cinque P.

BMC Infect Dis. 2011 Dec 14;11:343. doi: 10.1186/1471-2334-11-343.

50.

A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study.

Ricchi P, Ammirabile M, Costantini S, Di Matola T, Verna R, Diano A, Foglia MC, Spasiano A, Cinque P, Prossomariti L.

Ann Hematol. 2012 Jun;91(6):905-9. doi: 10.1007/s00277-011-1385-y. Epub 2011 Dec 15.

PMID:
22167341

Supplemental Content

Loading ...
Support Center